Follow
Matthias Bartneck
Matthias Bartneck
Medical clinic III - Gastroenterology and metabolic disease
Verified email at ukaachen.de - Homepage
Title
Cited by
Cited by
Year
Age-dependent alterations of monocyte subsets and monocyte-related chemokine pathways in healthy adults
S Seidler, HW Zimmermann, M Bartneck, C Trautwein, F Tacke
BMC immunology 11, 1-11, 2010
3902010
A positive feedback loop between RIP 3 and JNK controls non‐alcoholic steatohepatitis
J Gautheron, M Vucur, F Reisinger, DV Cardenas, C Roderburg, C Koppe, ...
EMBO molecular medicine 6 (8), 1062-1074, 2014
2982014
CCL2-dependent infiltrating macrophages promote angiogenesis in progressive liver fibrosis
J Ehling, M Bartneck, X Wei, F Gremse, V Fech, D Möckel, C Baeck, ...
Gut 63 (12), 1960-1971, 2014
2972014
Pharmacological inhibition of the chemokine C‐C motif chemokine ligand 2 (monocyte chemoattractant protein 1) accelerates liver fibrosis regression by suppressing Ly‐6C+ …
C Baeck, X Wei, M Bartneck, V Fech, F Heymann, N Gassler, K Hittatiya, ...
Hepatology 59 (3), 1060-1072, 2014
2622014
Rapid uptake of gold nanorods by primary human blood phagocytes and immunomodulatory effects of surface chemistry
M Bartneck, HA Keul, S Singh, K Czaja, J Bornemann, M Bockstaller, ...
ACS nano 4 (6), 3073-3086, 2010
2512010
Phagocytosis independent extracellular nanoparticle clearance by human immune cells
M Bartneck, HA Keul, G Zwadlo-Klarwasser, J Groll
Nano letters 10 (1), 59-63, 2010
2382010
Hepatic macrophage migration and differentiation critical for liver fibrosis is mediated by the chemokine receptor C‐C motif chemokine receptor 8 in mice
F Heymann, L Hammerich, D Storch, M Bartneck, S Huss, V Rüsseler, ...
Hepatology 55 (3), 898-909, 2012
1832012
Therapeutic targeting of liver inflammation and fibrosis by nanomedicine
M Bartneck, KT Warzecha, F Tacke
Hepatobiliary surgery and nutrition 3 (6), 364, 2014
1642014
Peptide-functionalized gold nanorods increase liver injury in hepatitis
M Bartneck, T Ritz, HA Keul, M Wambach, J Bornemann, U Gbureck, ...
Acs Nano 6 (10), 8767-8777, 2012
1602012
Topographical control of human macrophages by a regularly microstructured polyvinylidene fluoride surface
NE Paul, C Skazik, M Harwardt, M Bartneck, B Denecke, D Klee, J Salber, ...
Biomaterials 29 (30), 4056-4064, 2008
1572008
Inducing healing-like human primary macrophage phenotypes by 3D hydrogel coated nanofibres
M Bartneck, KH Heffels, Y Pan, M Bovi, G Zwadlo-Klarwasser, J Groll
Biomaterials 33 (16), 4136-4146, 2012
1422012
Fluorescent cell-traceable dexamethasone-loaded liposomes for the treatment of inflammatory liver diseases
M Bartneck, KM Scheyda, KT Warzecha, LY Rizzo, K Hittatiya, T Luedde, ...
Biomaterials 37, 367-382, 2015
1372015
Induction of specific macrophage subtypes by defined micro-patterned structures
M Bartneck, VA Schulte, NE Paul, M Diez, MC Lensen, ...
Acta biomaterialia 6 (10), 3864-3872, 2010
1062010
Liposomal encapsulation of dexamethasone modulates cytotoxicity, inflammatory cytokine response, and migratory properties of primary human macrophages
M Bartneck, FM Peters, KT Warzecha, M Bienert, L van Bloois, ...
Nanomedicine: nanotechnology, biology and medicine 10 (6), 1209-1220, 2014
1042014
Pharmacological intervention in hepatic stellate cell activation and hepatic fibrosis
HT Schon, M Bartneck, E Borkham-Kamphorst, T Lammers, F Tacke, ...
Frontiers in pharmacology 7, 180361, 2016
1012016
Histidine‐rich glycoprotein promotes macrophage activation and inflammation in chronic liver disease
M Bartneck, V Fech, J Ehling, O Govaere, KT Warzecha, K Hittatiya, ...
Hepatology 63 (4), 1310-1324, 2016
932016
The CCR2+ macrophage subset promotes pathogenic angiogenesis for tumor vascularization in fibrotic livers
M Bartneck, PL Schrammen, D Möckel, O Govaere, A Liepelt, O Krenkel, ...
Cellular and molecular gastroenterology and hepatology 7 (2), 371-390, 2019
852019
The necroptosis-inducing kinase RIPK3 dampens adipose tissue inflammation and glucose intolerance
J Gautheron, M Vucur, AT Schneider, I Severi, C Roderburg, S Roy, ...
Nature Communications 7 (1), 11869, 2016
762016
Targeting distinct myeloid cell populations in vivo using polymers, liposomes and microbubbles
C Ergen, F Heymann, F Gremse, M Bartneck, U Panzer, R Pola, M Pechar, ...
Biomaterials 114, 106-120, 2017
742017
Prognostic relevance of altered lymphocyte subpopulations in critical illness and sepsis
P Hohlstein, H Gussen, M Bartneck, KT Warzecha, C Roderburg, ...
Journal of clinical medicine 8 (3), 353, 2019
682019
The system can't perform the operation now. Try again later.
Articles 1–20